Catalent Indiana, LLC

Form 483 issued September 2, 2020 · Bloomington, Indiana

Inspection
Aug 27 – Sep 2, 2020
Investigator
Michael R. Shanks
Observations
1
Pages
1
FEI number
3005949964

In short: On September 2, 2020, FDA issued a Form 483 with 1 observation to Catalent Indiana, LLC in Bloomington, Indiana (FEI 3005949964) after an inspection that ran Aug 27 – Sep 2, 2020. The investigator was Michael R. Shanks. Most observations concern production; the most-cited regulation is 21 CFR 211.113 (control of microbiological contamination).

At a glance

1 of 1 observations on this 483 concern production.

Production1

Most cited: 21 CFR 211.113 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Catalent Indiana, LLC?

FDA listed 1 observation on this Form 483, mostly about production. The most-cited regulation is 21 CFR 211.113 (control of microbiological contamination). The opening words of each observation are shown on this page.

Who inspected Catalent Indiana, LLC?

Michael R. Shanks is named on this Form 483, for the inspection of Aug 27 – Sep 2, 2020. Each investigator has a profile showing what they cite most.

When was Catalent Indiana, LLC inspected by FDA?

The inspection ran Aug 27 – Sep 2, 2020, and the Form 483 is dated September 2, 2020.

How do I get the full Form 483 for Catalent Indiana, LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free